Invention Grant
- Patent Title: Bicyclic heterocycles as FGFR4 inhibitors
-
Application No.: US15874299Application Date: 2018-01-18
-
Publication No.: US10214528B2Publication Date: 2019-02-26
- Inventor: Liang Lu , Liangxing Wu , Ding-Quan Qian , Wenqing Yao
- Applicant: Incyte Corporation
- Applicant Address: US DE Wilmington
- Assignee: Incyte Corporation
- Current Assignee: Incyte Corporation
- Current Assignee Address: US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: C07D471/04
- IPC: C07D471/04
Abstract:
The present invention relates to bicyclic heterocycles, and pharmaceutical compositions of the same, that are inhibitors of the FGFR4 enzyme and are useful in the treatment of FGFR4-associated diseases such as cancer.
Public/Granted literature
- US20180244672A1 BICYCLIC HETEROCYCLES AS FGFR4 INHIBITORS Public/Granted day:2018-08-30
Information query
